Latest News in the pharma Industry

Research & Development

Collaboration to develop innovative technologies

Collaboration to develop innovative technologies

20 Dec 2017

Project will innovate technologies in epigenetic characterisation for patient stratification in renowned precision medicine.

Read more 
NIH study uncovers clues about why common cancer drug causes hearing loss

NIH study uncovers clues about why common cancer drug causes hearing loss

20 Dec 2017

Researchers find target to protect hearing during chemotherapy treatment.

Read more 
Regeneron and ISA Pharma to advance immuno-oncology treatment

Regeneron and ISA Pharma to advance immuno-oncology treatment

18 Dec 2017

Collaboration to conduct clinical trials of the combination treatment in both cervical and head-and-neck cancer.

Read more 
Major breakthrough for new haemophilia A treatment

Major breakthrough for new haemophilia A treatment

15 Dec 2017

Drug trials provide mind-blowing results.

Read more 
New formulation of Oncaspar receives Marketing Authorization in Europe for patients with ALL

New formulation of Oncaspar receives Marketing Authorization in Europe for patients with ALL

14 Dec 2017

Freeze-dried, or lyophilized, formulation aims to improve supply management by providing the same dosing regimen as liquid Oncaspar but with a three-times longer shelf life of up to 24 months.

Read more 
CMC Biologics and Harpoon Therapeutics collaborate on exciting new TriTAC molecules

CMC Biologics and Harpoon Therapeutics collaborate on exciting new TriTAC molecules

14 Dec 2017

First clinical candidate, HPN424, is in development for the treatment of metastatic prostate cancer and expected to enter Phase I clinical trials in 2018.

Read more 
Sanofi ends development of <i>Clostridium difficile</i> vaccine

Sanofi ends development of Clostridium difficile vaccine

4 Dec 2017

IDMC concludes that the study is unlikely to meet its primary objective.

Read more 
Novartis' Ultibro Breezhaler significantly improved COPD patients' lung function after direct switch from Seretide

Novartis' Ultibro Breezhaler significantly improved COPD patients' lung function after direct switch from Seretide

29 Nov 2017

Study provides further evidence that it is possible to reduce the burden of long-term inhaled steroids in many COPD patients.

Read more 
Company's new identity integrates services typically found in disparate CDMOs and CROs

Company's new identity integrates services typically found in disparate CDMOs and CROs

20 Nov 2017

Quotient Sciences Translational Pharmaceutics platform integrates formulation development, real-time adaptive GMP manufacturing and clinical research.

Read more 
New treatments to solve global antibiotic crisis could reach the market by 2020

New treatments to solve global antibiotic crisis could reach the market by 2020

19 Nov 2017

New ARB technology rejuvenates existing antibiotics to outsmart antibiotic resistance.

Read more 
Bavencio becomes first treatment for rare skin cancer mMCC licensed for use in the UK

Bavencio becomes first treatment for rare skin cancer mMCC licensed for use in the UK

7 Nov 2017

The launch of avelumab marks a step-change in the way that mMCC can be treated.

Read more 
Novartis seeks leadership with Cosentyx

Novartis seeks leadership with Cosentyx

6 Nov 2017

For the first time for any biologic, data show almost 80% of ankylosing spondylitis patients on Cosentyx have no radiographic progression of the spine at 4 years.

Read more